Mr. Speaker, actions speak louder than words.
Ten years ago, the government negotiated with drug companies to extend the monopoly period on new drugs. In exchange, the companies were supposed to invest 10% of their revenue in research and development in Canada. The reality is that only 4.5% of that revenue was invested in 2013.
Why does the minister not implement measures to make sure these companies keep their promises?